Prognostic Significance of β-Catenin in Relation to the Tumor Immune Microenvironment in Oral Cancer
Paloma Lequerica-Fernández,
Tania Rodríguez-Santamarta,
Eduardo García-García,
Verónica Blanco-Lorenzo,
Héctor E. Torres-Rivas,
Juan P. Rodrigo,
Faustino J. Suárez-Sánchez,
Juana M. García-Pedrero,
Juan Carlos De Vicente
Affiliations
Paloma Lequerica-Fernández
Department of Biochemistry, Hospital Universitario Central de Asturias (HUCA), Carretera de Rubín, 33011 Oviedo, Spain
Tania Rodríguez-Santamarta
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Carretera de Rubín, 33011 Oviedo, Spain
Eduardo García-García
Department of Oral and Maxillofacial Surgery, Hospital Universitario Central de Asturias (HUCA), Carretera de Rubín, 33011 Oviedo, Spain
Verónica Blanco-Lorenzo
Department of Pathology, Hospital Universitario Central de Asturias (HUCA), Carretera de Rubín, 33011 Oviedo, Spain
Héctor E. Torres-Rivas
Department of Pathology, Hospital Universitario Central de Asturias (HUCA), Carretera de Rubín, 33011 Oviedo, Spain
Juan P. Rodrigo
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Carretera de Rubín, 33011 Oviedo, Spain
Faustino J. Suárez-Sánchez
Department of Pathology, Hospital Universitario de Cabueñes, Prados, 33394 Gijon, Spain
Juana M. García-Pedrero
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Carretera de Rubín, 33011 Oviedo, Spain
Juan Carlos De Vicente
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Carretera de Rubín, 33011 Oviedo, Spain
The aim of this study was to investigate the prognostic relevance of β-catenin expression in oral squamous cell carcinoma (OSCC) and to explore relationships with the tumor immune microenvironment. Expression of β-catenin and PD-L1, as well as lymphocyte and macrophage densities, were evaluated by immunohistochemistry in 125 OSCC patient specimens. Membranous β-catenin expression was detected in 102 (81.6%) and nuclear β-catenin in 2 (1.6%) tumors. There was an association between β-catenin expression, tumoral, and stromal CD8+ T-cell infiltration (TIL) and also the type of tumor immune microenvironment (TIME). Tumors harboring nuclear β-catenin were associated with a type II TIME (i.e., immune ignorance defined by a negative PD-L1 expression and low CD8+ TIL density), whereas tumors with membranous β-catenin expression were predominantly type IV (i.e., immune tolerance defined by negative PD-L1 and high CD8+ TIL density). Combined, but not individual, high stromal CD8+ TILs and membranous β-catenin expression was independently associated with better disease-specific survival (HR = 0.48, p = 0.019). Taken together, a combination of high stromal CD8+ T-cell infiltration and membranous β-catenin in the tumor emerges as an independent predictor of better survival in OSCC patients.